. 2018 Oct 26;7(4):307–315. doi: 10.1016/j.imr.2018.10.001

Table 2.

Primary and secondary outcome parameters

Primary and secondary outcomes	Baseline	Third month	Fourth month (FU with no R_x)
Patient Global Impression Index of Improvement (PGI-I)
Mace (n = 30)	6.33 ± 0.49	2.76 ± 1.22^b***	2.66 ± 1.26^b***
Control (n = 30)	6.5 ± 0.62*	5.4 ± 0.67^b***	5.3 ± 0.6^b***
P value (Inter group)	>0.05^a	<0.001^a	<0.001^a

Patient Global Impression of Severity (PGI-S)
Mace (n = 30)	3.83 ± 0.37	2.33 ± 0.47^b***	1.96 ± 0.49^b***
Control (n = 30)	3.66 ± 0.54*	2.93 ± 0.52^b***	2.9 ± 0.48^b***
P value (Inter group)	>0.05^a	<0.001^a	<0.001^a

Secondary outcomes
Urinary Distress Inventory Questionnaire (UDI-6)
Mace (n = 30)	80.15 ± 10.26	29.06 ± 17.24^b***	28.13 ± 17.74^b***
Control (n = 30)	80.70 ± 12.07	55.18 ± 13.20^b***	55.91 ± 13.20^b***
P value	0.32^a	<0.0001^a	<0.0001^a

Short form of Incontinence Impact Questionnaire-7 (IIQ-7)
Mace (n = 30)	65.00 ± 9.75	19.51 ± 16.74^b***	18.24 ± 16.96^b***
Control (n = 30)	66.33 ± 13.28	42.84 ± 11.04^b***	42.84 ± 11.04^b***
P value	0.33^a	<0.0001^a	<0.0001^a

Short form of the Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)
Mace (n = 24)	28.91 ± 4.09	40.25 ± 4.80^c***	40.91 ± 5.19^c***
Control (n = 20)	27.55 ± 1.87	32.95 ± 2.66^c***	33 ± 2.61^c***
P value	0.07^d	<0.0001^d	<0.0001^d

The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
Mace (n = 30)	13.76 ± 1.83	5.66 ± 2.60^b***	4.56 ± 2.71^b***
Control (n = 30)	14.26 ± 1.72	11.83 ± 1.68^b**	11.8 ± 1.75^b***
P value	0.16^a	<0.0001^a	<0.0001^a

Data presented: mean ± SD or no. (%); *P > 0.05, considered not significant; **P < 0.05 considered significant; ***P < 0.0001, extremely significant (baseline vs. third month) & (baseline vs. follow-up); FU with no R_x: follow-up with no treatment; Test used: ^aMann–Whitney U test/^bWilcoxon Matched paired test,^cPaired/^dUnpaired Student's ‘t’ test.